Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips
Open Access
- 5 December 2022
- Vol. 26 (1) , 105723
Abstract
No abstract availableKeywords
Funding Information
- Shanghai General Hospital
- Natural Science Foundation of Shanghai Municipality (14YF1400600, 18ZR1404500, 21ZR1451600)
- National Natural Science Foundation of China (81402582, 82172884)
- Fudan University
- Huazhong University of Science and Technology
- National Key Research and Development Program of China (2020YFA0803202)
This publication has 37 references indexed in Scilit:
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision MedicineCancer Discovery, 2017
- Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2016
- The Future of Precision Medicine in OncologyClinics In Laboratory Medicine, 2016
- Impaired Lymphocytes Development and Xenotransplantation of Gastrointestinal Tumor Cells in Prkdc -Null SCID Zebrafish ModelNeoplasia, 2016
- The Emerging Hallmarks of Cancer MetabolismCell Metabolism, 2016
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer ResearchCancer Discovery, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Stroma and pancreatic ductal adenocarcinoma: An interaction loopBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Patient-derived tumour xenografts as models for oncology drug developmentNature Reviews Clinical Oncology, 2012
- Regulation of stearoyl-CoA desaturases and role in metabolismProgress in Lipid Research, 2004